We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
The fluorophore will fluoresce when it binds to glucose. The amount of fluorescence directly corresponds to the amount of glucose in the interstitial fluid. If ambient light (like sunlight) is high enough to interfere with measuring that fluorescence, the system will display a High Ambient Light Alert. No glucose will be displayed until the condition is resolved by reducing the ambient light condition.
The system is indicated (approved) for use to replace fingerstick blood glucose measurements for diabetes treatment decisions.
Pay close attention to your glucose values, symptoms, and trends. If your symptoms are different than the sensor glucose values or what the alert indicates, confirm your glucose value with a blood glucose meter test before making a treatment decision.*
To make a treatment decision, the user should consider:
When to NOT make a treatment decision:
* If you have any uncertainly in how or when to make treatment decisions, always speak with your healthcare professional.
Note: Always refer to the glucose information on your Eversense CGM App on your smartphone to make treatment decisions. Do not use a secondary display like the Apple Watch or Eversense NOW.
The Eversense® E3 Sensor and adhesive patches contain silicone. If you have any concerns about allergic reaction to silicones, contact your health care professional prior to use.
The proximity of the Eversense® E3 Sensor with medicated patches has not been studied. Please contact your health care professional for advisement.
Your Eversense Inserter will explain and perform the simple and quick steps to remove the sensor. You will be fully awake during the approximately 5-minute removal procedure.
Step 1: Site preparation – the sensor site will be cleaned, disinfected, then anesthetized using lidocaine.
Step 2: Incision – a small (~ 5-6mm) incision will be made at the sensor site.
Step 3: Sensor removal – the sensor will be removed and discarded.
Step 4: Site closure – once removed, the incision will be closed with Steri-Strips™ (sutures may be used depending on provider’s preference).
It is recommended to avoid areas with loose skin, scars, tattoos, nerves, or blood vessels that could be incised during the procedure.
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-GBL-0060